Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis
- 1 February 2008
- journal article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 638 (1-2) , 66-74
Abstract
No abstract availableKeywords
Funding Information
- Deutsche Krebshilfe (106356)
This publication has 34 references indexed in Scilit:
- Hyperactive Ras in developmental disorders and cancerNature Reviews Cancer, 2007
- Raf kinases: Oncogenesis and drug discoveryInternational Journal of Cancer, 2006
- The RAF proteins take centre stageNature Reviews Molecular Cell Biology, 2004
- Comparative biology of mouse versus human cells: modelling human cancer in miceNature Reviews Cancer, 2003
- RAS oncogenes: the first 30 yearsNature Reviews Cancer, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- Carcinogenesis in mouse and human cells: parallels and paradoxesCarcinogenesis, 2000
- Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumorsToxicology, 1995
- Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.Proceedings of the National Academy of Sciences, 1991